FLT3LG and neoplasm: CD40 agonists effectively promote cDC1 maturation, while the Flt3 ligand (Flt3L) helps to increase cDC1 abundance, and the synergistic effect of the two promotes superior T cell activation and enhances anti-tumor immunity (31).